These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 38456086)
21. A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea. Won YK; Kang KS; Gonzalez YS; Razavi H; Dugan E; Han KH; Ahn SH; Jeon MY; Kim DY PLoS One; 2020; 15(4):e0232186. PubMed ID: 32343727 [TBL] [Abstract][Full Text] [Related]
22. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis. Ward ZJ; Scott AM; Hricak H; Atun R Lancet Oncol; 2021 Mar; 22(3):341-350. PubMed ID: 33662286 [TBL] [Abstract][Full Text] [Related]
23. The global return on investment from preventing and treating adolescent mental disorders and suicide: a modelling study. Stelmach R; Kocher EL; Kataria I; Jackson-Morris AM; Saxena S; Nugent R BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35705224 [TBL] [Abstract][Full Text] [Related]
24. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries. Schäferhoff M; Zimmerman A; Diab MM; Mao W; Chowdhary V; Gill D; Karanja R; Madikizela M; Ogbuoji O; Yamey G Lancet Glob Health; 2022 Jul; 10(7):e1045-e1052. PubMed ID: 35714631 [TBL] [Abstract][Full Text] [Related]
25. Prevention and control of non-communicable diseases in iran: the case for Investment. Yousefi M; Dastan I; Alinezhad F; Ranjbar M; Hamelmann C; Ostovar A; Moghisi A; Mohammadi S; Mataria A; Hammerich A; Slama S; Pourghazian N; Hezaveh AM; Valizadeh B; Torabi P; Najmi M; Moradi M; Hodjatzadeh A; Keshvari-Shad F BMC Public Health; 2022 Jun; 22(1):1248. PubMed ID: 35739516 [TBL] [Abstract][Full Text] [Related]
26. Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017 Liu C; Shi J; Wang H; Yan X; Wang L; Ren J; Parascandola M; Chen W; Dai M Chin J Cancer Res; 2021 Feb; 33(1):79-92. PubMed ID: 33707931 [TBL] [Abstract][Full Text] [Related]
27. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis. Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987 [TBL] [Abstract][Full Text] [Related]
28. Malaria elimination transmission and costing in the Asia-Pacific: Developing an investment case. Shretta R; Silal SP; Celhay OJ; Gran Mercado CE; Kyaw SS; Avancena A; Fox K; Zelman B; Baral R; White LJ; Maude RJ Wellcome Open Res; 2019; 4():60. PubMed ID: 32025571 [No Abstract] [Full Text] [Related]
29. Developing an integrated microsimulation model for the impact of fiscal policies on child health in Europe: the example of childhood obesity in Italy. Rasella D; Richiardi L; Brachowicz N; Jara HX; Hanson M; Boccia D; Richiardi MG; Pizzi C BMC Med; 2021 Nov; 19(1):310. PubMed ID: 34844596 [TBL] [Abstract][Full Text] [Related]
30. Cost-utility and cost-benefit analyses of school-based obesity prevention program. Xu H; Li Y; Du S; Zhang Q; Liu A; Sun J; Ma G BMC Public Health; 2020 Oct; 20(1):1608. PubMed ID: 33097026 [TBL] [Abstract][Full Text] [Related]
31. Benefit-cost analysis of a H7N9 vaccination program in poultry in Guangxi, China. Tang H; Kang J; Shen C; Wang Y; Robertson ID; Cai C; Edwards J; Huang B; Bruce M Prev Vet Med; 2022 Mar; 200():105580. PubMed ID: 35032782 [TBL] [Abstract][Full Text] [Related]
32. Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally. Bastawrous A; Suni AV Ophthalmic Epidemiol; 2020 Apr; 27(2):115-120. PubMed ID: 31810404 [No Abstract] [Full Text] [Related]
33. Estimating the risk of declining funding for malaria in Ghana: the case for continued investment in the malaria response. Shretta R; Silal SP; Malm K; Mohammed W; Narh J; Piccinini D; Bertram K; Rockwood J; Lynch M Malar J; 2020 Jun; 19(1):196. PubMed ID: 32487148 [TBL] [Abstract][Full Text] [Related]
34. The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation. Elmusharaf K; Grafton D; Jung JS; Roberts E; Al-Farsi Y; Al Nooh AA; Bin Belaila B; ElShamy A; Al-Zuabi H; Al Mutawa KA; Alraisi S; Al Lawat N; Gharbal A; Alomary S; Kulikov A; Pourghazian N; Slama S; Tarlton D; Banatvala N BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35649631 [TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness and budget impact of universal varicella vaccination in Russia. Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445 [TBL] [Abstract][Full Text] [Related]
36. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach. Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631 [TBL] [Abstract][Full Text] [Related]
37. [Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences]. Shi JF; Mao AY; Bai YN; Liu GX; Liu CC; Wang H; Cao MM; Feng H; Wang L; Bai FZ; Huang HY; Bai HJ; Zhu J; Yan XX; Zhang J; Ren JS; Li N; Dai M; Chen WQ Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):306-313. PubMed ID: 32187937 [No Abstract] [Full Text] [Related]